En esta página
01BMY precio
02Instantánea
03Gráfico
04Divisiones de acciones
05Acerca de
06Rendimiento
07Valoración y ratios
13Dividendos
14Ganancias
15Fundamentales Completos
16Estados Financieros
17Propietarios institucionales (13F)
18Activistas y propietarios del %+ 5
19Informantes de la empresa
20Propiedad de ETFs
21Consenso
22Pares
23Noticias
26Mis Métricas
BMY Bristol-Myers Squibb Company Common Stock
NYSE · Pharmaceuticals · Ver en SEC EDGAR ↗ 10-K/10-Q Jul 30, 2026
$61,48
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$42,52mínimo 52 semanas
$68,64máximo 52 semanas
P/E (TTM)
13.5
BPA (TTM)
$4.55
Ingresos (TTM)
$49.19B
tus insignias
Rango 52S
$43–$69
Calificación del Analista
HOLD
Precio Objetivo
$65
P/E
13.5
ROE
46.7%
Margen de Beneficio Neto
18.9%
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
BMY Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$61.48
P/E (TTM)
13.5
BPA (TTM)
$4.55
Ingresos (TTM)
$49.19B
ROE (TTM)
46.7%
Deuda/Capital (MRQ)
2.0
Rango 52S
$43–$69
BMY Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Divisiones de acciones
| Fecha ex-dividendo | División | Tipo |
|---|---|---|
| 7 de agosto de 2001 | 394-for-375 | Adelante |
| 1 de marzo de 1999 | 2-for-1 | Adelante |
| 3 de marzo de 1997 | 2-for-1 | Adelante |
| 10 de junio de 1987 | 2-for-1 | Adelante |
| 27 de mayo de 1983 | 2-for-1 | Adelante |
| 31 de mayo de 1977 | 2-for-1 | Adelante |
Acerca de Bristol-Myers Squibb Company Common Stock Descripción general de la empresa de Wikipedia
Bristol-Myers Squibb, a menudo conocido como BMS, es una compañía farmacéutica, con sede en la ciudad de Nueva York. La empresa se formó en 1989, tras la fusión de sus predecesores de Bristol-Myers y la Corporación de Squibb. Squibb fue fundado en 1858 por Edward Robinson Squibb en Brooklyn, Nueva York, mientras que Bristol-Myers fue fundada en 1887 por William McLaren Bristol y John Ripley Myers en Clinton, Condado de Oneida, Nueva York, (ambos eran graduados de Hamilton College (Nueva York). Bristol-Myers Squibb fabrica productos farmacéuticos de prescripción en varias áreas terapéuticas, incluyendo cáncer, VIH/SIDA, enfermedades cardiovasculares, diabetes, hepatitis, artritis reumatoide y trastornos psiquiátricos. Su misión es "descubrir, desarrollar y ofrecer medicamentos innovadores que ayudan a los pacientes a superar enfermedades graves". Sitios primarios de R & D 'BMS se encuentran en Princeton, New Jersey (anteriormente Squibb) y Wallingford, Connecticut (anteriormente Bristol-Myers), con otros sitios en Hopewell y Nueva Brunswick, Nueva Jersey y en Braine-l ' Alleud, Bélgica, Tokio y Bangalore, India.
Historia
En 1999, el Presidente Bill Clinton otorgó a Bristol-Myers Squibb la Medalla Nacional de Tecnología, máximo reconocimiento de la nación para logros, muy bien tecnológicos "por extender y mejorar la vida humana a través de la investigación farmacéutica innovadora y el desarrollo y la redefinición de la ciencia del estudio clínico a través de ensayos clínicos innovadores y enormemente complejos que son modelos reconocidos en la industria." En 2005, BMS estaba entre las 53 entidades que contribuyeron el máximo de $250,000 a la investidura presidencial de Bush. En noviembre de 2009, Bristol-Myers Squibb anunció que era "partner" de Mead Johnson Nutrition, ofreciendo a los accionistas BMY la oportunidad de intercambiar sus acciones por las de Mead Johnson. Con el acuerdo con Bristol-Myers Squibb, se esperaba que este movimiento agudizase el enfoque de la compañía en productos biofarmacéuticos.
BMS es una compañía del Fortune 500 (#114 en la lista de 2010). 2009 Verde Ranking de Newsweek había reconocido a Bristol-Myers Squibb dentro del grupo de las 8 corporaciones más grandes de Estados Unidos. También, BMS fue incluida en el índice del Dow Jones Sustainability Norteamérica 2009 de compañías basadas en la sostenibilidad. En octubre de 2010, la compañía adquirió ZymoGenetics, asegurando la producción de medicamentos contra el cáncer, la hepatitis C y otras áreas terapéuticas.
En enero de 2019, la Justicia de EE.UU demandó al grupo farmacéutico Bristol-Myers Squibb, por participar en la década de 1940 en un experimento que afectó, con distintas enfermedades venéreas como sífilis y gonorrea, a miles de guatemaltecos.
Taxol
Al mismo tiempo, BMS celebró el contrato solitario para cosechar la corteza de árboles en peligro de extinción de Taxus brevifolia en territorio de Estados Unidos para la fabricación de medicinas de quimioterapia (Taxol). La producción actual proviene de fuentes renovables. BMS también celebró la licencia original de paclitaxel, pero ahora hay varios productores genéricos.
Fuente: Wikipedia, CC BY-SA 4.0 · Ver en Wikipedia ↗
sectorHealthcare
industriaPharmaceuticals
empleados32 500
paísUS
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$48.19B2019-12-31 → 2025-12-31
BPA$3.462019-12-31 → 2025-12-31
Flujo de caja libre$12.85B2019-12-31 → 2025-12-31
Margen neto18.9%2019-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | BMY | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E (TTM) | 13.5promedio 5A ≈12.1 | ≈12.1 | 31.0 | Infravalorado |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | BMY | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| EBITDA Margin (Margen EBITDA) | 8.3%promedio 5A ≈19.0% | ≈19.0% | 8.3% | Débil | |
| Margen antes de impuestos (TTM) | 24.2%promedio 5A ≈11.0% | ≈11.0% | 15.0% | De primer nivel | |
| Margen de Beneficio Neto (TTM) | 18.9%promedio 5A ≈8.5% | ≈8.5% | 10.4% | De primer nivel | |
| ROA (TTM) | 10.2%promedio 5A ≈3.8% | ≈3.8% | 9.8% | Por debajo del promedio | |
| ROE (TTM) | 46.7%promedio 5A ≈13.2% | ≈13.2% | 25.3% | De primer nivel |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | BMY | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Deuda / Patrimonio (MRQ) | 2.0promedio 5A ≈2.0 | ≈2.0 | 0.9 | Deuda alta | |
| Ratio corriente (MRQ) | 1.5promedio 5A ≈1.3 | ≈1.3 | 1.6 | En línea | |
| Quick Ratio (Ratio Rápido) | 0.8promedio 5A ≈0.9 | ≈0.9 | 0.8 | Liquidez sólida | |
| Deuda a Largo Plazo / Patrimonio (MRQ) | 1.9promedio 5A ≈1.7 | ≈1.7 | 0.9 | Deuda alta |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | BMY | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | -0.22%promedio 5A ≈2.6% | ≈2.6% | · | · | |
| Revenue CAGR 3Y (Ingresos CAGR 3A) | 1.5%promedio 5A ≈1.6% | ≈1.6% | · | · | |
| Revenue CAGR 5Y (Ingresos CAGR 5A) | 2.5% | · | · | · | |
| EPS YoY (EPS interanual) | 30.9% | · | · | · | |
| Net Income YoY (Beneficio Neto interanual) | 26.8% | · | · | · | |
| EPS CAGR 3Y (CAGR BPA 3A) | 5.5% | · | · | · | |
| Net Income CAGR 3Y (CAGR Beneficio Neto 3A) | 3.7% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | BMY | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.5promedio 5A ≈0.5 | ≈0.5 | 0.5 | En línea | |
| Inventory Turnover (Rotación de Inventario) | 5.3promedio 5A ≈4.9 | ≈4.9 | 1.5 | De primer nivel | |
| Receivables Turnover (Rotación de Cuentas por Cobrar) | 5.2promedio 5A ≈5.5 | ≈5.5 | 5.6 | Débil | |
| Revenue / Employee (Ingresos / Empleado) | ≈$1.5M | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Dividendos Rendimiento, ratio de pago, historial de dividendos, CAGR a 5 años
Ratio de Pago71.5%
Pago anualizado≈$2.52
CAGR de Dividendos a 5 años≈6.6%
Racha de Crecimiento≈16
| Fecha ex-dividendo | Monto | Moneda | Rendimiento |
|---|---|---|---|
| Oct 2, 2026 | $0,63 | USD | ≈4.1% |
| Jul 2, 2026 | $0,63 | USD | ≈4.3% |
| Abr 2, 2026 | $0,63 | USD | ≈4.2% |
| Ene 2, 2026 | $0,63 | USD | ≈4.7% |
| Oct 3, 2025 | $0,62 | USD | ≈5.5% |
| Jul 3, 2025 | $0,62 | USD | ≈5.2% |
| Abr 4, 2025 | $0,62 | USD | ≈4.4% |
| Ene 3, 2025 | $0,62 | USD | ≈4.3% |
| Oct 4, 2024 | $0,60 | USD | ≈4.4% |
| Jul 5, 2024 | $0,60 | USD | ≈6.0% |
| Abr 4, 2024 | $0,60 | USD | ≈4.6% |
| Ene 4, 2024 | $0,60 | USD | ≈4.4% |
| Oct 5, 2023 | $0,57 | USD | ≈4.0% |
| Jul 6, 2023 | $0,57 | USD | ≈3.5% |
| Abr 6, 2023 | $0,57 | USD | ≈3.1% |
| Ene 5, 2023 | $0,57 | USD | ≈3.0% |
| Oct 6, 2022 | $0,54 | USD | ≈3.1% |
| Jun 30, 2022 | $0,54 | USD | ≈2.7% |
| Mar 31, 2022 | $0,54 | USD | ≈2.8% |
| Ene 6, 2022 | $0,54 | USD | ≈3.3% |
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
18.5%
Próximo informe
Oct 29, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Jul 30, 2026 | $2.04 | $1.60 | 27.2% |
| 31 de marzo de 2026 | $1.58 | $1.43 | 10.4% | |
| 31 de diciembre de 2025 | $1.26 | $1.13 | 11.9% | |
| 30 de septiembre de 2025 | $1.63 | $1.52 | 6.9% | |
| 30 de junio de 2025 | $1.46 | $1.08 | 35.0% | |
| 31 de marzo de 2025 | $1.80 | $1.51 | 19.4% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $48.19B | $48.30B | $45.01B | $46.16B | $46.38B | $42.52B | $26.14B | $22.56B | $20.78B | $19.43B | $16.56B | $15.88B | |
| Cost of Revenue | $13.94B | $13.97B | $10.69B | $10.14B | $9.94B | $11.77B | $8.08B | $6.47B | $6.01B | $4.97B | $3.91B | $3.93B | |
| Gross Profit | · | · | · | · | · | $30.75B | $18.07B | $16.09B | $14.68B | $14.48B | $12.65B | $11.95B | |
| R&D Expense | $9.95B | $11.16B | $9.30B | $9.51B | $10.20B | $10.05B | $6.15B | $6.33B | $6.47B | $5.01B | $5.92B | $4.53B | |
| SG&A Expense | $7.27B | $8.41B | $7.77B | $7.81B | $7.69B | $7.66B | $4.87B | $4.55B | $4.75B | $4.98B | $4.84B | $4.82B | |
| Operating Expenses | $38.87B | $56.68B | $36.57B | $38.45B | $38.29B | $49.39B | $21.17B | $16.59B | $15.64B | $13.51B | $14.48B | $13.50B | |
| Interest Expense | · | · | $1.17B | $1.23B | $1.33B | $1.42B | $656M | $183M | $196M | $167M | $184M | $203M | |
| Interest Income | $586M | $478M | $449M | $171M | $39M | $121M | $464M | $173M | $126M | $97M | $101M | $101M | |
| Other Non-op | $-674M | $-893M | $1.16B | $-576M | $720M | $2.31B | $-938M | $854M | $1.69B | $1.45B | $187M | $-210M | |
| Pretax Income | $9.33B | $-8.38B | $8.44B | $7.71B | $8.10B | $-6.87B | $4.97B | $5.97B | $5.13B | $5.92B | $2.08B | $2.38B | |
| Income Tax | $2.27B | $554M | $400M | $1.37B | $1.08B | $2.12B | $1.51B | $1.02B | $4.16B | $1.41B | $446M | $352M | |
| Net Income | $7.05B | $-8.95B | $8.03B | $6.33B | $6.99B | $-9.02B | $3.44B | $4.92B | $1.01B | $4.46B | $1.56B | $2.00B | |
| EPS (Basic) | $3.47 | $-4.41 | $3.88 | $2.97 | $3.15 | $-3.99 | $2.02 | $3.01 | $0.61 | $2.67 | $0.94 | $1.21 | |
| EPS (Diluted) | $3.46 | $-4.41 | $3.86 | $2.95 | $3.12 | $-3.99 | $2.01 | $3.01 | $0.61 | $2.65 | $0.93 | $1.20 | |
| Shares (Basic) | 2,034,000,000 | 2,027,000,000 | 2,069,000,000 | 2,130,000,000 | 2,221,000,000 | 2,258,000,000 | 1,705,000,000 | 1,633,000,000 | 1,645,000,000 | 1,671,000,000 | 1,667,000,000 | 1,657,000,000 | |
| Shares (Diluted) | 2,039,000,000 | 2,027,000,000 | 2,078,000,000 | 2,146,000,000 | 2,245,000,000 | 2,258,000,000 | 1,712,000,000 | 1,637,000,000 | 1,652,000,000 | 1,680,000,000 | 1,679,000,000 | 1,670,000,000 | |
| EBITDA | $4.01B | $9.60B | $9.76B | $10.28B | $10.69B | $10.38B | $1.75B | $637M | $789M | $382M | $376M | $467M |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $10.21B | $10.35B | $11.46B | $9.12B | $13.98B | $14.55B | $12.35B | $6.91B | $5.42B | $4.24B | $2.38B | $5.57B | |
| Short-term Investments | · | · | · | $130M | $2.99B | $1.28B | $3.05B | $1.85B | $1.39B | $2.11B | $1.89B | $1.86B | |
| Receivables | $9.59B | $9.01B | $8.88B | $8.15B | $7.98B | $7.22B | $6.48B | $4.64B | $4.35B | $3.77B | $2.95B | $2.10B | |
| Inventory | $2.69B | $2.56B | $2.66B | $2.34B | $2.10B | $2.07B | $4.29B | $1.20B | $1.17B | $1.24B | $1.22B | $1.56B | |
| Prepaid Expense | · | · | · | · | · | · | · | · | $576M | $570M | $625M | $470M | |
| Other Current Assets | $4.61B | $5.62B | $5.91B | $5.79B | $4.83B | $3.79B | $1.98B | $2.02B | $576M | $570M | $625M | $470M | |
| Current Assets | $29.39B | $29.78B | $31.77B | $27.27B | $33.26B | $30.19B | $29.35B | $17.72B | $14.85B | $13.70B | $10.41B | $14.61B | |
| PP&E (Net) | $7.54B | $7.14B | $6.65B | $6.25B | $6.05B | $5.89B | $6.25B | $5.03B | $5.00B | $4.98B | $4.41B | $4.42B | |
| PP&E (Gross) | $12.84B | $12.09B | $11.45B | $10.42B | $10.08B | $9.47B | $10.21B | $8.85B | $8.99B | $9.17B | $8.63B | $9.07B | |
| Accum. Depreciation | $5.29B | $4.95B | $4.80B | $4.16B | $4.03B | $3.58B | $3.96B | $3.82B | $3.99B | $4.19B | $4.22B | $4.65B | |
| Goodwill | $21.75B | $21.72B | $21.17B | $21.15B | $20.50B | $20.55B | $22.49B | $6.54B | $6.86B | $6.88B | $6.88B | $7.03B | |
| Intangibles | $19.10B | $23.31B | $27.07B | $35.86B | $42.53B | $53.24B | $63.97B | $1.09B | $1.21B | $1.39B | $1.42B | $1.75B | |
| Other Non-current Assets | $6.47B | $6.11B | $5.37B | $4.94B | $5.54B | $7.02B | $6.60B | $2.02B | $1.53B | $1.05B | $1.12B | $621M | |
| Total Assets | $90.04B | $92.60B | $95.16B | $96.82B | $109.31B | $118.48B | $129.94B | $34.99B | $33.55B | $33.71B | $31.75B | $33.75B | |
| Accounts Payable | $3.58B | $3.60B | $3.26B | $3.04B | $2.95B | $2.71B | $2.44B | $1.89B | $2.25B | $1.66B | $1.56B | $2.49B | |
| Accrued Liabilities | · | · | · | · | · | · | · | $6.49B | $6.01B | $5.27B | $4.74B | $2.46B | |
| Short-term Debt | $2.26B | $2.05B | $3.12B | $4.26B | $4.95B | $2.34B | $3.35B | $1.70B | $987M | $109M | $139M | $590M | |
| Current Liabilities | $23.42B | $23.77B | $22.26B | $21.89B | $21.87B | $19.08B | $18.30B | $10.65B | $9.56B | $8.84B | $8.02B | $8.46B | |
| Capital Leases | $1.83B | $1.37B | $1.53B | $1.26B | $874M | $833M | $672M | $0 | · | · | · | · | |
| Deferred Tax | $222M | $369M | $338M | $2.17B | $4.50B | $5.41B | $6.45B | $19M | $45M | $47M | $31M | $60M | |
| Other Non-current Liabilities | $5.04B | $4.47B | $6.42B | $6.59B | $7.33B | $7.78B | $10.10B | $4.54B | $1.16B | $1.28B | $1.43B | $618M | |
| Total Liabilities | $71.53B | $76.22B | $65.67B | $65.70B | $73.31B | $80.60B | $78.25B | $20.86B | $21.70B | $17.36B | $17.32B | $18.77B | |
| Long-term Debt | $44.83B | $49.43B | $39.53B | $38.95B | $44.37B | $50.34B | $46.15B | $6.89B | $6.97B | $6.46B | · | · | |
| Total Debt | $47.09B | $51.48B | $42.65B | $43.22B | $49.32B | $52.68B | $49.50B | $8.60B | $7.49B | $7.46B | $6.69B | $7.83B | |
| Common Stock | · | · | · | $292M | $292M | $292M | $292M | $221M | $221M | $221M | $221M | $221M | |
| Paid-in Capital | $46.39B | $46.02B | $45.68B | $45.16B | $44.36B | $44.33B | $43.71B | $2.08B | $1.90B | $1.73B | $1.46B | $1.51B | |
| Retained Earnings | $16.90B | $14.91B | $28.77B | $25.50B | $23.82B | $21.28B | $34.47B | $34.06B | $31.16B | $33.51B | $31.61B | $32.54B | |
| Treasury Stock | $43.58B | $43.66B | $43.77B | $38.62B | $31.26B | $26.24B | $25.36B | $19.57B | $19.25B | $16.78B | $16.56B | $16.99B | |
| AOCI | $-1.52B | $-1.24B | $-1.55B | $-1.28B | $-1.27B | $-1.84B | $-1.52B | $-2.76B | $-2.29B | $-2.50B | $-2.47B | $-2.42B | |
| Stockholders' Equity | $18.47B | $16.34B | $29.43B | $31.06B | $35.95B | $37.82B | $51.60B | $14.03B | $11.74B | $16.18B | $14.27B | $14.85B | |
| Liabilities + Equity | $90.04B | $92.60B | $95.16B | $96.82B | $109.31B | $118.48B | $129.94B | $34.99B | $33.55B | $33.71B | $31.75B | $33.75B |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4.01B | $9.60B | $9.76B | $10.28B | $10.69B | $10.38B | $1.75B | $637M | $789M | $382M | $376M | $467M | |
| Stock-based Comp | $553M | $507M | $518M | $457M | $583M | $779M | $441M | $221M | $199M | $205M | $235M | $213M | |
| Deferred Tax | $-965M | $-2.09B | $-3.29B | $-2.74B | $-1.39B | $983M | $-924M | $45M | $453M | $-204M | $-347M | $-542M | |
| Amort. of Intangibles | $3.50B | $9.00B | $9.20B | $9.70B | $10.20B | $9.90B | $1.30B | $198M | $190M | $178M | $183M | $286M | |
| Restructuring | $563M | $635M | $365M | $75M | $169M | $530M | $301M | $131M | $293M | $109M | $118M | $163M | |
| Other Non-cash | $3.50B | $16.12B | $-1.16B | $-1.26B | $-663M | $10.93B | $3.37B | $76M | $2.27B | $-1.99B | $3M | $1.01B | |
| Operating Cash Flow | $14.16B | $15.19B | $13.86B | $13.07B | $16.21B | $14.05B | $8.21B | $7.07B | $5.28B | $3.06B | $2.10B | $3.15B | |
| CapEx | $1.31B | $1.25B | $1.21B | $1.12B | $973M | $753M | $836M | $951M | $1.05B | $1.22B | $820M | $526M | |
| Investing Cash Flow | $-4.13B | $-21.35B | $-2.29B | $-1.06B | $-538M | $-10.86B | $-9.91B | $-2.00B | $-66M | $1.48B | $-1.57B | $1.22B | |
| Debt Issued | $5.74B | $12.88B | $4.46B | $5.93B | $0 | $6.95B | $26.78B | $0 | $1.49B | $0 | $1.27B | · | |
| Net Debt Issued | $-5.20B | $10.01B | $576M | $-5.50B | $-6.02B | $4.20B | $17.52B | $-5M | $264M | $-15M | $-689M | $-676M | |
| Stock Repurchased | $0 | $0 | $5.16B | $8.00B | $6.29B | $1.55B | $7.30B | $320M | $2.47B | $231M | · | · | |
| Net Stock Activity | $0 | $0 | $-5.16B | $-8.00B | $-6.29B | $-1.55B | $-7.30B | $-320M | $-2.47B | $-231M | · | · | |
| Dividends Paid | $5.04B | $4.86B | $4.74B | $4.63B | $4.40B | $4.08B | $2.68B | $2.61B | $2.58B | $2.55B | $2.48B | $2.40B | |
| Financing Cash Flow | $-10.35B | $5.13B | $-9.42B | $-16.96B | $-16.22B | $-1.15B | $7.62B | $-3.54B | $-4.08B | $-2.65B | $-3.62B | $-2.44B | |
| Net Change in Cash | $-129M | $-1.17B | $2.19B | $-4.99B | $-657M | $2.15B | $5.91B | $1.49B | $1.18B | $1.85B | $-3.19B | $1.99B | |
| Taxes Paid | $3.26B | $3.90B | $4.30B | $5.40B | $3.50B | $3.40B | $1.50B | $747M | $546M | $2.00B | $577M | $544M | |
| Free Cash Flow | $12.85B | $13.94B | $12.65B | $11.95B | $15.23B | $13.30B | $7.23B | $4.99B | $4.22B | $1.64B | $1.01B | $2.62B | |
| Levered FCF | · | · | $11.54B | $10.93B | $14.08B | $11.44B | $6.77B | $4.84B | $4.18B | $1.51B | $868M | $2.45B |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | 72.3% | 69.1% | 71.0% | 70.8% | 74.5% | 76.4% | 75.2% | |
| Net Margin | 14.6% | -18.5% | 17.8% | 13.7% | 15.1% | -21.2% | 13.2% | 21.8% | 4.9% | 22.9% | 9.4% | 12.6% | |
| Pretax Margin | 19.4% | -17.3% | 18.8% | 16.7% | 17.5% | -16.2% | 19.0% | 26.5% | 24.7% | 30.4% | 12.5% | 15.0% | |
| EBITDA Margin | 8.3% | 19.9% | 21.7% | 22.3% | 23.0% | 24.4% | 6.7% | 2.8% | 3.8% | 2.0% | 2.3% | 2.9% | |
| ROA | 7.7% | -9.5% | 8.4% | 6.1% | 6.1% | -7.4% | 3.7% | 14.3% | 3.0% | 13.2% | 4.9% | 6.0% | |
| ROE | 40.5% | -39.1% | 26.5% | 18.9% | 19.0% | -20.2% | 10.5% | 38.2% | 7.2% | 29.3% | 10.8% | 13.4% |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.3 | 1.4 | 1.2 | 1.5 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.3 | 1.7 | |
| Quick Ratio | 0.8 | 0.8 | 0.9 | 0.8 | 1.1 | 1.2 | 1.2 | 1.3 | 1.2 | 1.1 | 0.9 | 1.1 | |
| Debt / Equity | 2.5 | 3.2 | 1.4 | 1.4 | 1.4 | 1.4 | 1.0 | 0.6 | 0.6 | 0.5 | 0.5 | 0.5 | |
| LT Debt / Equity | 2.3 | 2.9 | 1.2 | 1.1 | 1.1 | 1.3 | 0.8 | 0.4 | 0.6 | 0.4 | 0.5 | 0.5 |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | 0.5 | 0.4 | 0.4 | 0.3 | 0.3 | 0.7 | 0.6 | 0.6 | 0.5 | 0.5 | |
| Inventory Turnover | 5.3 | 5.4 | 4.3 | 4.6 | 4.8 | 3.7 | 2.9 | 5.5 | 5.0 | 4.0 | 2.8 | 2.6 | |
| Receivables Turnover | 5.2 | 5.4 | 5.3 | 5.7 | 6.1 | 6.2 | 4.7 | 5.0 | 5.1 | 5.8 | 6.6 | 8.4 |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $23.64 | $23.83 | $21.66 | $21.51 | $20.66 | $18.83 | $15.27 | $13.78 | $12.58 | $11.56 | $9.86 | $9.51 | |
| Cash Flow / Share | $6.94 | $7.49 | $6.67 | $6.09 | $7.22 | $6.22 | $4.71 | $3.63 | $3.19 | $1.70 | $1.09 | $1.89 | |
| Dividend / Share | $2.49 | $2.42 | $2.31 | $2.19 | $2.01 | $1.84 | $1.68 | $1.61 | $1.57 | $1.53 | $1.49 | $1.45 | |
| EPS (TTM) | $3.46 | $-4.41 | $3.86 | $2.95 | $3.12 | $-3.99 | $2.01 | $3.01 | $0.61 | $2.65 | $0.93 | $1.20 |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -0.22% | 7.3% | -2.5% | -0.49% | 9.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 1.5% | 1.4% | 1.9% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 2.5% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | 30.9% | -5.5% | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 5.5% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | 26.8% | -9.5% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 3.7% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 4.4% | · | · | · | · | · | · | · | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $48.19B | $48.30B | $45.01B | $46.16B | $46.38B | $42.52B | $26.14B | $22.56B | $20.78B | $19.43B | $16.56B | $15.88B | |
| Net Income TTM | $7.05B | $-8.95B | $8.03B | $6.33B | $6.99B | $-9.02B | $3.44B | $4.92B | $1.01B | $4.46B | $1.56B | $2.00B | |
| P/E | 15.6 | -12.8 | 13.3 | 24.4 | 20.0 | -15.5 | 31.9 | 17.3 | 100.5 | 22.1 | 74.0 | 49.2 | |
| Earnings Yield | 6.4% | -7.8% | 7.5% | 4.1% | 5.0% | -6.4% | 3.1% | 5.8% | 1.0% | 4.5% | 1.4% | 2.0% | |
| Payout Ratio | 71.5% | -54.4% | 59.1% | 73.2% | 62.8% | -45.2% | 77.9% | 53.1% | 255.9% | 57.1% | 158.3% | 119.7% | |
| Annual Payout | $5.04B | $4.86B | $4.74B | $4.63B | $4.40B | $4.08B | $2.68B | $2.61B | $2.58B | $2.55B | $2.48B | $2.40B |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12.97B | $11.49B | $12.50B | $12.22B | $12.27B | $11.20B | $12.34B | $11.89B | $12.20B | $11.87B | $11.48B | $10.97B | $11.23B | $11.34B | $11.41B | $11.22B | |
| Cost of Revenue | $3.73B | $3.42B | $4.10B | $3.44B | $3.37B | $3.03B | $4.81B | $2.96B | $3.27B | $2.93B | $2.75B | $2.51B | $2.88B | $2.57B | $2.59B | $2.35B | |
| R&D Expense | $2.96B | $2.65B | $2.59B | $2.53B | $2.58B | $2.26B | $3.19B | $2.37B | $2.90B | $2.69B | $2.48B | $2.24B | $2.26B | $2.32B | $2.51B | $2.42B | |
| SG&A Expense | $1.83B | $1.62B | $2.18B | $1.79B | $1.71B | $1.58B | $2.14B | $1.98B | $1.93B | $2.37B | $2.07B | $2.00B | $1.93B | $1.76B | $2.27B | $1.93B | |
| Operating Expenses | $8.89B | $8.25B | $11.03B | $9.11B | $10.50B | $8.23B | $12.17B | $10.22B | $10.91B | $23.38B | $9.80B | $8.83B | $9.37B | $8.57B | $9.55B | $9.01B | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $425M | · | $280M | $282M | $288M | · | $299M | |
| Interest Income | $101M | $104M | $148M | $161M | $139M | $138M | $114M | $94M | $87M | $183M | $145M | $107M | $95M | $102M | $82M | $52M | |
| Other Non-op | $61M | $-32M | $51M | $108M | $-494M | $-339M | $-305M | $-234M | $-273M | $-81M | $371M | $258M | $116M | $413M | $217M | $140M | |
| Pretax Income | $4.09B | $3.24B | $1.47B | $3.11B | $1.77B | $2.97B | $175M | $1.68B | $1.29B | $-11.52B | $1.67B | $2.14B | $1.86B | $2.77B | $1.86B | $2.21B | |
| Income Tax | $770M | $561M | $384M | $919M | $460M | $509M | $99M | $461M | $-398M | $392M | $-88M | $203M | $-218M | $503M | $-166M | $601M | |
| Net Income | $3.32B | $2.68B | $1.09B | $2.20B | $1.31B | $2.46B | $72M | $1.21B | $1.68B | $-11.91B | $1.76B | $1.93B | $2.07B | $2.26B | $2.02B | $1.61B | |
| EPS (Basic) | $1.62 | $1.31 | $0.54 | $1.08 | $0.64 | $1.21 | $0.05 | $0.60 | $0.83 | $-5.89 | $0.87 | $0.94 | $0.99 | $1.08 | $0.95 | $0.75 | |
| EPS (Diluted) | $1.62 | $1.31 | $0.54 | $1.08 | $0.64 | $1.20 | $0.05 | $0.60 | $0.83 | $-5.89 | $0.87 | $0.93 | $0.99 | $1.07 | $0.95 | $0.75 | |
| Shares (Basic) | 2,042,000,000 | 2,038,000,000 | · | 2,036,000,000 | 2,035,000,000 | 2,031,000,000 | · | 2,028,000,000 | 2,027,000,000 | 2,023,000,000 | · | 2,057,000,000 | 2,093,000,000 | 2,099,000,000 | · | 2,133,000,000 | |
| Shares (Diluted) | 2,048,000,000 | 2,047,000,000 | · | 2,039,000,000 | 2,038,000,000 | 2,040,000,000 | · | 2,031,000,000 | 2,029,000,000 | 2,023,000,000 | · | 2,064,000,000 | 2,102,000,000 | 2,113,000,000 | · | 2,148,000,000 | |
| EBITDA | · | $594M | · | · | · | $1.01B | · | · | · | $2.53B | · | · | · | $2.43B | · | · |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8.72B | $9.57B | $10.21B | $15.73B | $12.60B | $10.88B | $10.35B | $7.89B | $6.29B | $9.33B | · | $7.51B | $8.37B | $8.99B | · | $7.73B | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | $171M | $358M | $274M | · | $1.29B | |
| Receivables | $9.08B | $7.95B | $9.59B | $9.62B | $9.71B | $9.06B | $9.01B | $9.32B | $9.75B | $8.83B | · | $8.41B | $8.12B | $7.85B | · | $8.02B | |
| Inventory | $2.74B | $2.76B | $2.69B | $2.76B | $2.74B | $2.67B | $2.56B | $3.33B | $3.08B | $2.98B | · | $2.44B | $2.36B | $2.60B | · | $2.07B | |
| Other Current Assets | $4.22B | $4.60B | $4.61B | $4.95B | $5.47B | $5.53B | $5.62B | $5.62B | $5.74B | $5.57B | · | $7.21B | $6.87B | $5.16B | · | $6.08B | |
| Current Assets | $28.58B | $27.21B | $29.39B | $35.63B | $33.22B | $30.78B | $29.78B | $28.07B | $26.89B | $28.67B | · | $27.63B | $28.07B | $27.09B | · | $26.80B | |
| PP&E (Net) | $7.79B | $7.66B | $7.54B | $7.35B | $7.37B | $7.21B | $7.14B | $6.90B | $6.84B | $6.75B | · | $6.48B | $6.36B | $6.28B | · | $6.04B | |
| PP&E (Gross) | $13.34B | $13.09B | $12.84B | $12.54B | $12.68B | $12.32B | $12.09B | $11.74B | $11.93B | $11.69B | · | $11.13B | $10.83B | $10.52B | · | $10.17B | |
| Accum. Depreciation | $5.55B | $5.43B | $5.29B | $5.20B | $5.31B | $5.11B | $4.95B | $4.84B | $5.09B | $4.94B | · | $4.65B | $4.48B | $4.24B | · | $4.14B | |
| Goodwill | $21.74B | $21.74B | $21.75B | $21.75B | $21.78B | $21.74B | $21.72B | $21.75B | $21.73B | $21.74B | $21.17B | $21.15B | $21.16B | $21.16B | $21.15B | $21.11B | |
| Intangibles | $17.39B | $18.24B | $19.10B | $20.46B | $21.38B | $22.49B | $23.31B | $26.96B | $29.43B | $32.76B | · | $28.95B | $31.30B | $33.57B | · | $38.18B | |
| Other Non-current Assets | $6.38B | $6.08B | $6.47B | $6.33B | $5.94B | $5.87B | $6.11B | $6.04B | $6.07B | $6.02B | · | $5.21B | $5.02B | $4.87B | · | $4.75B | |
| Total Assets | $87.63B | $86.48B | $90.04B | $96.89B | $94.68B | $92.43B | $92.60B | $93.67B | $94.65B | $99.03B | · | $91.26B | $93.49B | $94.28B | · | $98.20B | |
| Accounts Payable | $4.16B | $4.23B | $3.58B | $4.29B | $5.43B | $4.00B | $3.60B | $3.47B | $3.75B | $3.54B | · | $2.81B | $3.07B | $3.19B | · | $2.60B | |
| Short-term Debt | $1.03B | $2.31B | $2.26B | $4.51B | $4.71B | $3.55B | $2.05B | $1.08B | $3.53B | $6.19B | · | $5.47B | $3.02B | $2.75B | · | $2.13B | |
| Current Liabilities | $18.66B | $19.16B | $23.42B | $28.14B | $27.53B | $24.07B | $23.77B | $22.64B | $23.27B | $25.82B | · | $23.46B | $20.15B | $19.09B | · | $18.93B | |
| Capital Leases | $1.73B | $1.77B | $1.83B | $1.85B | $1.55B | $1.36B | $1.37B | $1.48B | $1.44B | $1.56B | · | $1.51B | $1.34B | $1.37B | · | $845M | |
| Deferred Tax | $222M | $211M | $222M | $225M | $247M | $276M | $369M | $430M | $461M | $442M | · | $399M | $751M | $1.57B | · | $2.88B | |
| Other Non-current Liabilities | $4.34B | $4.85B | $5.04B | $5.46B | $4.94B | $4.48B | $4.47B | $4.73B | $4.99B | $6.73B | · | $6.20B | $5.90B | $6.66B | · | $6.68B | |
| Total Liabilities | $65.31B | $66.37B | $71.53B | $78.29B | $77.19B | $74.98B | $76.22B | $76.47B | $77.58B | $82.48B | · | $62.20B | $61.46B | $62.40B | · | $65.46B | |
| Long-term Debt | $42.86B | $44.14B | $44.83B | $48.72B | $48.95B | $49.51B | $49.43B | $49.55B | $51.95B | $52.36B | · | $37.01B | $37.07B | $37.33B | · | $38.87B | |
| Total Debt | $43.89B | $46.45B | · | $53.23B | $53.66B | $53.06B | · | $50.62B | $55.48B | $58.55B | · | $42.48B | $40.09B | $40.08B | · | $41.00B | |
| Common Stock | · | · | · | · | · | · | · | · | · | · | · | · | $292M | $292M | · | $292M | |
| Paid-in Capital | $46.50B | $46.37B | $46.39B | $46.27B | $46.13B | $46.01B | $46.02B | $45.90B | $45.77B | $45.66B | · | $44.85B | $45.30B | $45.14B | · | $44.96B | |
| Retained Earnings | $20.32B | $18.29B | $16.90B | $17.09B | $16.15B | $16.11B | $14.91B | $16.10B | $16.10B | $15.64B | · | $28.22B | $27.45B | $26.57B | · | $24.68B | |
| Treasury Stock | $43.50B | $43.52B | $43.58B | $43.59B | $43.59B | $43.60B | $43.66B | $43.67B | $43.69B | $43.70B | · | $43.08B | $39.68B | $38.81B | · | $36.41B | |
| AOCI | $-1.29B | $-1.37B | $-1.52B | $-1.51B | $-1.55B | $-1.42B | $-1.24B | $-1.47B | $-1.46B | $-1.40B | · | $-1.29B | $-1.39B | $-1.37B | · | $-841M | |
| Stockholders' Equity | $22.32B | $20.07B | $18.47B | $18.55B | $17.43B | $17.39B | $16.34B | $17.14B | $17.02B | $16.49B | · | $29.00B | $31.97B | $31.82B | · | $32.67B | |
| Liabilities + Equity | $87.63B | $86.48B | $90.04B | $96.89B | $94.68B | $92.43B | $92.60B | $93.67B | $94.65B | $99.03B | · | $91.26B | $93.49B | $94.28B | · | $98.20B |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $594M | $594M | $977M | $1.01B | $1.01B | $1.01B | $1.88B | $2.59B | $2.60B | $2.53B | $2.46B | $2.44B | $2.43B | $2.43B | $2.52B | $2.59B | |
| Stock-based Comp | $135M | $146M | $133M | $139M | $137M | $144M | $120M | $129M | $125M | $133M | $127M | $132M | $137M | $122M | $119M | $115M | |
| Deferred Tax | $-195M | $161M | $-392M | $-359M | $-437M | $223M | $-791M | $-256M | $-331M | $-711M | $-1.33B | $-327M | $-1.09B | $-548M | $-624M | $-645M | |
| Amort. of Intangibles | $471M | $472M | $906M | $867M | $864M | $863M | $1.80B | $2.40B | $2.40B | $2.40B | $2.30B | $2.30B | $2.30B | $2.30B | $2.30B | $2.50B | |
| Restructuring | $56M | $5M | $132M | $75M | $223M | $133M | $77M | $78M | $260M | $220M | $44M | $141M | $113M | $67M | $15M | $17M | |
| Other Non-cash | · | $-2.47B | · | · | · | $-1.88B | · | · | · | $12.79B | · | · | · | $-1.29B | · | · | |
| Operating Cash Flow | $3.39B | $1.10B | $1.97B | $6.31B | $3.92B | $1.95B | $4.44B | $5.59B | $2.33B | $2.83B | $4.25B | $4.75B | $1.89B | $2.97B | $3.31B | $3.69B | |
| CapEx | $305M | $347M | $370M | $320M | $361M | $260M | $378M | $324M | $262M | $284M | $330M | $342M | $259M | $278M | $346M | $247M | |
| Investing Cash Flow | $-1.61B | $-131M | $-1.46B | $-1.70B | $-473M | $-499M | $-196M | $-219M | $-1.32B | $-19.62B | $-1.35B | $-410M | $-329M | $-210M | $1.21B | $-2.08B | |
| Debt Issued | · | · | $5.74B | $0 | $0 | $0 | $0 | $0 | $0 | $12.88B | · | · | · | · | $26M | $0 | |
| Net Debt Issued | · | $-500M | · | · | · | $0 | · | · | · | $0 | · | · | · | $-1.64B | · | · | |
| Stock Repurchased | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $4.00B | $905M | $250M | $2.42B | $701M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $-250M | · | $-701M | |
| Dividends Paid | $1.29B | $1.28B | $1.26B | $1.26B | $1.26B | $1.26B | $1.22B | $1.22B | $1.22B | $1.21B | $1.16B | $1.19B | $1.20B | $1.20B | $1.15B | $1.15B | |
| Financing Cash Flow | $-2.63B | $-1.56B | $-6.03B | $-1.49B | $-1.84B | $-993M | $-1.64B | $-3.85B | $-4.02B | $14.64B | $967M | $-5.16B | $-2.17B | $-3.05B | $-3.25B | $-4.54B | |
| Net Change in Cash | $-861M | $-635M | $-5.51B | $3.12B | $1.74B | $528M | $2.45B | $1.60B | $-3.04B | $-2.19B | $3.95B | $-857M | $-623M | $-277M | $1.37B | $-3.00B | |
| Taxes Paid | · | $239M | $1.06B | $400M | $1.56B | $235M | $800M | $1.00B | $1.91B | $187M | $200M | $1.00B | $2.95B | $149M | $1.50B | $1.20B | |
| Free Cash Flow | · | $757M | · | · | · | $1.69B | · | · | · | $2.55B | · | · | · | $2.69B | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $2.11B | · | · | · | $2.46B | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 25.6% | 23.3% | · | 18.0% | 10.7% | 21.9% | · | 10.2% | 13.8% | -100.4% | · | 17.6% | 18.5% | 20.0% | · | 14.3% | |
| Pretax Margin | 31.5% | 28.2% | · | 25.5% | 14.4% | 26.5% | · | 14.1% | 10.5% | -97.1% | · | 19.5% | 16.6% | 24.4% | · | 19.7% | |
| EBITDA Margin | · | 5.2% | · | · | · | 9.0% | · | · | · | 21.3% | · | · | · | 21.4% | · | · | |
| ROA | 3.6% | 3.0% | · | 2.3% | 1.4% | 2.6% | · | 1.3% | 1.8% | -12.3% | · | 2.0% | 2.1% | 2.3% | · | 1.5% | |
| ROE | 16.7% | 14.3% | · | 12.3% | 7.6% | 14.5% | · | 5.2% | 6.9% | -49.3% | · | 6.2% | 6.4% | 7.1% | · | 4.6% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 1.4 | · | 1.3 | 1.2 | 1.3 | · | 1.2 | 1.2 | 1.1 | · | 1.2 | 1.4 | 1.4 | · | 1.4 | |
| Quick Ratio | 1.0 | 0.9 | · | 0.9 | 0.8 | 0.8 | · | 0.8 | 0.7 | 0.7 | · | 0.7 | 0.8 | 0.9 | · | 0.9 | |
| Debt / Equity | 2.0 | 2.3 | · | 2.9 | 3.1 | 3.1 | · | 3.0 | 3.3 | 3.6 | · | 1.5 | 1.3 | 1.3 | · | 1.3 | |
| LT Debt / Equity | 1.9 | 2.1 | · | 2.4 | 2.6 | 2.7 | · | 2.8 | 2.9 | 3.0 | · | 1.1 | 1.1 | 1.1 | · | 1.1 |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 1.4 | 1.3 | · | 1.1 | 1.2 | 1.1 | · | 1.0 | 1.2 | 1.0 | · | 1.1 | 1.3 | 1.1 | · | 1.1 | |
| Receivables Turnover | 1.4 | 1.4 | · | 1.3 | 1.3 | 1.3 | · | 1.3 | 1.4 | 1.4 | · | 1.3 | 1.4 | 1.5 | · | 1.4 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $6.33 | $5.61 | · | $5.99 | $6.02 | $5.49 | · | $5.86 | $6.01 | $5.87 | · | $5.31 | $5.34 | $5.37 | · | $5.22 | |
| Cash Flow / Share | · | $0.54 | · | · | · | $0.96 | · | · | · | $1.40 | · | · | · | $1.41 | · | · | |
| Dividend / Share | $0.63 | $0.63 | $0.63 | $0.62 | $0.62 | $0.62 | $0.62 | $0.60 | $0.60 | $0.60 | $0.60 | $0.57 | $0.57 | $0.57 | $0.57 | $0.54 | |
| EPS (TTM) | $4.55 | $3.57 | · | $2.97 | $2.49 | $2.68 | · | $-3.59 | $-3.26 | $-3.10 | · | $3.94 | $3.76 | $3.43 | · | $3.07 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $49.19B | $48.48B | · | $48.03B | $47.70B | $47.64B | · | $47.44B | $46.51B | $45.53B | · | $44.94B | $45.19B | $45.85B | · | $46.74B | |
| Net Income TTM | $9.28B | $7.28B | · | $6.04B | $5.05B | $5.42B | · | $-7.26B | $-6.54B | $-6.15B | · | $8.29B | $7.96B | $7.31B | · | $6.68B | |
| P/E | 12.7 | 17.0 | · | 15.2 | 18.6 | 22.8 | · | -14.4 | -12.7 | -17.5 | · | 14.7 | 17.0 | 20.2 | · | 23.2 | |
| Earnings Yield | 7.9% | 5.9% | · | 6.6% | 5.4% | 4.4% | · | -6.9% | -7.8% | -5.7% | · | 6.8% | 5.9% | 5.0% | · | 4.3% | |
| Payout Ratio | · | 47.9% | · | · | · | 51.2% | · | · | · | -10.2% | · | · | · | 52.9% | · | · | |
| Annual Payout | $5.09B | $5.07B | · | $5.00B | $4.95B | $4.91B | · | $4.80B | $4.78B | $4.76B | · | $4.73B | $4.69B | $4.64B | · | $4.59B |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $48.19B | $48.30B | $45.01B | $46.16B | $46.38B |
| Beneficio neto | $7.05B | $-8.95B | $8.03B | $6.33B | $6.99B |
| EPS Diluido | $3.46 | $-4.41 | $3.86 | $2.95 | $3.12 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Deuda / Patrimonio | 2.5 | 3.2 | 1.4 | 1.4 | 1.4 |
| Ratio corriente | 1.3 | 1.3 | 1.4 | 1.2 | 1.5 |
| Ratio Rápido | 0.8 | 0.8 | 0.9 | 0.8 | 1.1 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $12.85B | $13.94B | $12.65B | $11.95B | $15.23B |
Propietarios institucionales (13F) 2 784 declarantes · $106.4B total · A fecha de 30 de septiembre de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
2 784
Valor en tenencia
$106.4B
Nuevas posiciones
161
Posiciones cerradas
156
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 161 (-163 vs trimestre anterior) | 156 (+19 vs trimestre anterior) | 1 020 (-44 vs trimestre anterior) | 1 037 (+137 vs trimestre anterior) | +76.1M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| VANGUARD GROUP INC | $10 719 375 805 | 198 727 768 | 10,07% | Acciones |
| BlackRock, Inc. | $10 393 783 402 | 180 384 994 | 9,77% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $7 682 927 263 | 133 337 856 | 7,22% | Acciones |
| STATE STREET CORP | $5 900 803 123 | 102 408 940 | 5,55% | Acciones |
| JPMORGAN CHASE & CO | $4 199 539 317 | 71 713 442 | 3,95% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $3 894 834 109 | 67 595 177 | 3,66% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $3 243 917 787 | 56 443 077 | 3,05% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2 700 823 125 | 46 873 015 | 2,54% | Acciones |
| NORGES BANK | $2 124 256 834 | 36 866 658 | 2,00% | Acciones |
| BANK OF AMERICA CORP /DE/ | $1 961 693 190 | 34 045 352 | 1,84% | Acciones |
| MORGAN STANLEY | $1 671 500 291 | 29 009 025 | 1,57% | Acciones |
| AQR CAPITAL MANAGEMENT LLC | $1 576 338 331 | 27 357 486 | 1,48% | Acciones |
| AMERIPRISE FINANCIAL INC | $1 536 458 132 | 26 670 064 | 1,44% | Acciones |
| PRIMECAP MANAGEMENT CO/CA/ | $1 436 115 120 | 24 923 900 | 1,35% | Acciones |
| NORTHERN TRUST CORP | $1 435 797 287 | 24 918 384 | 1,35% | Acciones |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $1 377 926 759 | 22 719 320 | 1,29% | Acciones |
| Bank of New York Mellon Corp | $1 257 348 170 | 21 821 384 | 1,18% | Acciones |
| Independent Franchise Partners LLP | $1 255 703 498 | 21 792 841 | 1,18% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $1 134 827 730 | 19 691 951 | 1,07% | Acciones |
| Legal & General Group Plc | $980 861 802 | 17 022 940 | 0,92% | Acciones |
| GOLDMAN SACHS GROUP INC | $980 507 996 | 17 016 799 | 0,92% | Acciones |
| PZENA INVESTMENT MANAGEMENT LLC | $979 945 875 | 17 007 044 | 0,92% | Acciones |
| FMR LLC | $938 820 087 | 16 293 303 | 0,88% | Acciones |
| Invesco Ltd. | $923 849 120 | 16 033 480 | 0,87% | Acciones |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $716 010 426 | 12 226 954 | 0,67% | Acciones |
| ROYAL BANK OF CANADA | $696 908 000 | 12 094 886 | 0,65% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $660 776 941 | 11 467 840 | 0,62% | Acciones |
| Allianz Asset Management GmbH | $654 767 001 | 11 363 537 | 0,62% | Acciones |
| VAN ECK ASSOCIATES CORP | $588 737 536 | 10 217 590 | 0,55% | Acciones |
| VICTORY CAPITAL MANAGEMENT INC | $585 933 423 | 10 168 924 | 0,55% | Acciones |
| DEUTSCHE BANK AG\ | $584 450 089 | 10 143 181 | 0,55% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $581 119 768 | 10 085 383 | 0,55% | Acciones |
| UBS Group AG | $511 460 414 | 8 876 439 | 0,48% | Acciones |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $494 716 447 | 8 585 846 | 0,46% | Acciones |
| NORDEA INVESTMENT MANAGEMENT AB | $462 886 120 | 8 052 294 | 0,44% | Acciones |
| Robeco Institutional Asset Management B.V. | $449 298 598 | 7 200 298 | 0,42% | Acciones |
| TWO SIGMA ADVISERS, LP | $446 094 588 | 8 270 200 | 0,42% | Acciones |
| Amundi | $430 681 412 | 7 474 537 | 0,40% | Acciones |
| FIL Ltd | $375 902 104 | 6 523 813 | 0,35% | Acciones |
| WELLS FARGO & COMPANY/MN | $364 253 053 | 6 321 643 | 0,34% | Acciones |
| FIRST TRUST ADVISORS LP | $344 672 508 | 5 981 822 | 0,32% | Acciones |
| Capital International Investors | $340 767 005 | 5 913 752 | 0,32% | Acciones |
| Swiss National Bank | $331 822 056 | 5 758 800 | 0,31% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $324 590 746 | 5 633 300 | 0,31% | Opción de venta |
| National Pension Service | $321 412 139 | 5 578 135 | 0,30% | Acciones |
| Mitsubishi UFJ Asset Management Co., Ltd. | $319 229 612 | 5 540 268 | 0,30% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $316 480 270 | 5 492 542 | 0,30% | Acciones |
| HSBC HOLDINGS PLC | $312 617 268 | 5 409 898 | 0,29% | Acciones |
| M&G PLC | $306 949 282 | 5 292 229 | 0,29% | Acciones |
| Nuveen, LLC | $300 327 792 | 5 212 215 | 0,28% | Acciones |
Activistas y propietarios del %+ 5 11 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY, CELGENE CORPORATION ×3 presentaciones | 16 de julio de 2020 | · | Presentación inicial | · | SEC |
| Wellington Management Group LLP, Wellington Group Holdings LLP, Wellington Investment Advisors Holdings LLP, Wellington Management Company LLP | 27 de febrero de 2019 | · | Presentación inicial | Inversión pasiva | SEC |
| S.S. OR ×3 presentaciones | 23 de diciembre de 2009 | · | Presentación inicial | · | SEC |
| Medarex, Inc. S.S. OR, S.S. OR | 25 de noviembre de 2009 | · | Presentación inicial | · | SEC |
| Identification Nos. of Above Persons (entities only) Bristol-Myers Squibb Company ×2 presentaciones | 27 de febrero de 2009 | · | Presentación inicial | · | SEC |
| Bristol -Myers Squibb Company, Bristol -Myers Squibb Biologics Company ×3 presentaciones | 8 de octubre de 2008 | · | Presentación inicial | · | SEC |
| Bristol-Myers Squibb Company I.R.S. Employer Identification Number 22-079-0350 ×3 presentaciones | 6 de junio de 2003 | · | Presentación inicial | · | SEC |
| Persona informante no revelada | 16 de abril de 2003 | · | Presentación inicial | · | SEC |
| Persona informante no revelada | 3 de febrero de 2003 | · | Presentación inicial | · | SEC |
| Persona informante no revelada | 6 de marzo de 2002 | · | Presentación inicial | · | SEC |
| Persona informante no revelada | 6 de febrero de 2002 | · | Presentación inicial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 102 insiders · 65 directivos · 37 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Christopher S. Boerner | Chief Executive Officer | 10 de marzo de 2026 A | 21 451 | 0 | 0 | $0 |
| Peter R Dolan | Former CEO | 8 de septiembre de 2006 F | 571 673 | 0 | 0 | $0 |
| David V Elkins | EVP, Chief Financial Officer | 1 de abril de 2026 S | 159 248 | 0 | 2 | $-1 850 016 |
| Jean-Marc Huet | EVP & CFO | 30 de abril de 2009 P | 25 000 | 0 | 0 | $0 |
| Lynelle Hoch | President, Cell Therapy Org. | 10 de marzo de 2026 A | 8 210 | 0 | 0 | $0 |
| Benjamin Hickey | President, RayzeBio Org. | 10 de marzo de 2026 A | 16 672 | 0 | 0 | $0 |
| James B D Palmer DR | CSO & President, PRI | 2 de marzo de 2004 A | 178 889 | 0 | 0 | $0 |
| Dean J Mitchell | President, U.S. Primary Care | 10 de septiembre de 2003 A | 60 000 | 0 | 0 | $0 |
| Cari Gallman | EVP, General Counsel | 2 de octubre de 2026 M | 15 876 | 0 | 0 | $0 |
| Cristian Massacesi | EVP,Chief Med Offr,Head of Dev | 9 de septiembre de 2026 S | 18 748 | 0 | 1 | $-403 498 |
| Bartie Wendy Short | EVP, Corporate Affairs | 1 de septiembre de 2026 M | 12 684 | 0 | 0 | $0 |
| Phil M Holzer | SVP and Controller | 25 de agosto de 2026 S | 16 862 | 0 | 1 | $-33 750 |
| Adam Lenkowsky | EVP, Chief Commercial Officer | 1 de mayo de 2026 M | 19 706 | 0 | 0 | $0 |
| Karin Shanahan | EVP, Chief Supply Chain & Ops | 1 de abril de 2026 M | 25 888 | 0 | 0 | $0 |
| Hiroshi Chris Shibutani | EVP, Chief Strategy Officer | 10 de marzo de 2026 A | · | 0 | 0 | $0 |
| Ahn Amanda Poole | EVP, Chief People Officer | 10 de marzo de 2026 A | 7 094 | 0 | 0 | $0 |
| Gregory Scott Meyers | EVP, Chief Digital & Tech Off. | 10 de marzo de 2026 A | 30 361 | 0 | 0 | $0 |
| Robert M Plenge | EVP, Chief Research Officer | 10 de marzo de 2026 A | 21 528 | 0 | 0 | $0 |
| Samit Hirawat | EVP,Chief Med.Offr.,Drug Dev. | 25 de abril de 2025 P | 83 513 | 0 | 0 | $0 |
| Sandra Leung | EVP, General Counsel | 10 de marzo de 2025 A | 364 296 | 0 | 0 | $0 |
| Giovanni Caforio | Executive Chair of the Board | 10 de marzo de 2024 M | 432 266 | 0 | 0 | $0 |
| Ann Powell Judge | EVP, Chief Human Resources | 24 de agosto de 2023 S | 27 868 | 0 | 0 | $0 |
| Michelle Weese | EVP, Corporate Affairs | 1 de julio de 2023 M | 3 453 | 0 | 0 | $0 |
| Rupert Vessey | EVP & President, Research | 3 de mayo de 2023 S | 47 751 | 0 | 0 | $0 |
| Sharon Greenlees | SVP & Controller | 2 de mayo de 2023 M | 609 | 0 | 0 | $0 |
| Elizabeth Mily | EVP, Strategy & BD | 1 de abril de 2023 M | 34 734 | 0 | 0 | $0 |
| Karen Murphy Santiago | SVP & Controller | 14 de marzo de 2022 S | 16 704 | 0 | 0 | $0 |
| Paul Von Autenried | EVP, Chief Information Officer | 24 de noviembre de 2021 S | 63 536 | 0 | 0 | $0 |
| Adam Dubow | SVP,ChiefCompliance&EthicsOff. | 30 de julio de 2021 S | 13 777 | 0 | 0 | $0 |
| Joseph Eid | SVP,Head Glob. Medical Affairs | 3 de junio de 2021 M | 9 485 | 0 | 0 | $0 |
| Louis S Schmukler | EVP,Pres.,Glob.Prod. & Supply | 10 de mayo de 2021 S | 31 956 | 0 | 0 | $0 |
| Kathryn Metcalfe | EVP, Corporate Affairs | 10 de marzo de 2020 A | · | 0 | 0 | $0 |
| John E Elicker | EVP, Investor Relations | 10 de marzo de 2020 M | 70 946 | 0 | 0 | $0 |
| Charles A Bancroft | EVP, Head of Integration | 10 de marzo de 2020 M | 137 534 | 0 | 0 | $0 |
| Paul Biondi | SVP, Head of Strategy & BD | 2 de octubre de 2019 M | 6 214 | 0 | 0 | $0 |
| Thomas J. Lynch Jr. | EVP & Chief Scientific Officer | 3 de abril de 2019 M | 22 223 | 0 | 0 | $0 |
| Murdo Gordon | EVP, Chief Commercial Officer | 1 de agosto de 2018 M | 49 424 | 0 | 0 | $0 |
| Joseph C Caldarella | SVP & Controller | 6 de septiembre de 2017 S | 46 297 | 0 | 0 | $0 |
| Anne Nielsen | Chief Compliance & Ethics Off | 3 de septiembre de 2017 M | 37 974 | 0 | 0 | $0 |
| Emmanuel Blin | SVP, Chief Strategy Officer | 10 de marzo de 2017 A | 20 138 | 0 | 0 | $0 |
| Francis M Cuss | EVP & CSO | 10 de marzo de 2017 M | 321 906 | 0 | 0 | $0 |
| Samuel J Moed | SVP, Strat Plan & Analysis | 13 de marzo de 2015 S | 31 015 | 0 | 0 | $0 |
| Brian Daniels | SVP Global Dev & Med Affairs | 1 de julio de 2014 M | 94 374 | 0 | 0 | $0 |
| Frances K Heller | SVP, Business Development | 10 de marzo de 2014 A | 4 174 | 0 | 0 | $0 |
| Elliot Sigal | EVP, CSO & President R&D | 3 de junio de 2013 M | 148 221 | 0 | 0 | $0 |
| Beatrice J Cazala | EVP Commercial Operations | 31 de mayo de 2013 S | 173 375 | 0 | 0 | $0 |
| John E Celentano | SVP HR Public Affairs & Philan | 6 de marzo de 2012 M | 142 142 | 0 | 0 | $0 |
| Jeremy M Levin | SVP Strat Transactions | 1 de octubre de 2011 M | 43 689 | 0 | 0 | $0 |
| De Notaristefani Carlo | Pres Tech Ops & Supp Fnctns | 14 de junio de 2011 M | 7 578 | 0 | 0 | $0 |
| Anthony C Hooper | SVP ComOps Pres USJap Int | 13 de mayo de 2011 M | 203 170 | 0 | 0 | $0 |
| Anthony A Mcbride | SVP Human Resources | 6 de marzo de 2010 M | 29 786 | 0 | 0 | $0 |
| Robert T Zito | SVP & Chief Comm Officer | 6 de marzo de 2010 M | 34 584 | 0 | 0 | $0 |
| Stephen E Bear | SVP, Human Resources | 2 de marzo de 2008 F | 66 940 | 0 | 0 | $0 |
| Tamar D Howson | SVP, Corp & Bus Development | 1 de diciembre de 2006 A | 71 465 | 0 | 0 | $0 |
| Andrew G Bodnar | SVP, Strat & Med & Ext Affairs | 8 de septiembre de 2006 F | 306 482 | 0 | 0 | $0 |
| David L Zabor | VP Strat Bus Initiatives | 30 de junio de 2006 F | 62 829 | 0 | 0 | $0 |
| Wendy L Dixon | CMO & Pres, Global Marketing | 22 de mayo de 2006 F | 87 003 | 0 | 0 | $0 |
| Richard L Wolgemuth | SVP, Global Reg Sciences | 7 de marzo de 2006 A | 45 016 | 0 | 0 | $0 |
| Edward M Dwyer | Vice President & Treasurer | 7 de marzo de 2006 A | 19 417 | 0 | 0 | $0 |
| Richard K Willard | SVP & General Counsel | 7 de marzo de 2006 A | 120 000 | 0 | 0 | $0 |
| John L Mcgordrick | Executive VP | 7 de marzo de 2006 F | 221 219 | 0 | 0 | $0 |
| Donald J Hayden JR | EVP and President, Americas | 1 de marzo de 2005 A | 207 649 | 0 | 0 | $0 |
| Paul W Karr | VP & Financial Controller | 15 de marzo de 2004 A | 8 222 | 0 | 0 | $0 |
| Harrison M Bains JR | VP, Tax and Treasury | 2 de marzo de 2004 A | 70 652 | 0 | 0 | $0 |
| John L Skule III | SVP, Corp & Envirn Affairs | 24 de marzo de 1998 M | 39 857 | 0 | 0 | $0 |
| Theodore R. Samuels II | Consejero | 30 de septiembre de 2026 A | 35 500 | 0 | 0 | $0 |
| Michael R. Mcmullen | Consejero | 30 de septiembre de 2026 A | · | 0 | 0 | $0 |
| Derica W Rice | Consejero | 30 de septiembre de 2026 A | · | 0 | 0 | $0 |
| Peter J Arduini | Consejero | 30 de septiembre de 2026 A | · | 0 | 0 | $0 |
| Phyllis R Yale | Consejero | 30 de septiembre de 2026 A | · | 0 | 0 | $0 |
| Julia A Haller | Consejero | 15 de junio de 2026 M | 34 079 | 0 | 0 | $0 |
| Deepak Bhatt | Consejero | 1 de febrero de 2026 A | · | 0 | 0 | $0 |
| Medina Manuel Hidalgo | Consejero | 1 de febrero de 2026 A | · | 0 | 0 | $0 |
| Karen H Vousden | Consejero | 1 de febrero de 2026 A | · | 0 | 0 | $0 |
| Gerald L Storch | Consejero | 31 de marzo de 2024 A | · | 0 | 0 | $0 |
| Michael W Bonney | Consejero | 30 de junio de 2021 A | 12 501 | 0 | 0 | $0 |
| Dinesh C Paliwal | Consejero | 31 de marzo de 2021 A | 22 109 | 0 | 0 | $0 |
| Matthew Emmens | Consejero | 31 de marzo de 2021 A | · | 0 | 0 | $0 |
| Robert J Bertolini | Consejero | 31 de marzo de 2021 A | 11 397 | 0 | 0 | $0 |
| Vicki L Sato | Consejero | 1 de febrero de 2021 A | · | 0 | 0 | $0 |
| Michael Grobstein | Consejero | 30 de junio de 2020 A | 5 000 | 0 | 0 | $0 |
| Alan J Lacy | Consejero | 30 de junio de 2020 A | 2 305 | 0 | 0 | $0 |
| Jose Baselga | Consejero | 30 de septiembre de 2018 A | · | 0 | 0 | $0 |
| Lamberto Andreotti | Consejero | 7 de abril de 2017 S | 935 571 | 0 | 0 | $0 |
| Laurie H Glimeher | Consejero | 1 de febrero de 2017 A | 0 | 0 | 0 | $0 |
| Togo D West JR | Consejero | 1 de febrero de 2017 A | · | 0 | 0 | $0 |
| Lewis B Campbell | Consejero | 8 de marzo de 2016 M | 0 | 0 | 0 | $0 |
| James M Cornelius | Consejero | 31 de marzo de 2015 A | 79 851 | 0 | 0 | $0 |
| Sanders R Williams | Consejero | 1 de febrero de 2013 A | · | 0 | 0 | $0 |
| Louis J Freeh | Consejero | 1 de febrero de 2013 A | · | 0 | 0 | $0 |
| Leif Johansson | Consejero | 1 de febrero de 2011 A | · | 0 | 0 | $0 |
| James D Robinson III | Consejero | 1 de febrero de 2008 A | 38 646 | 0 | 0 | $0 |
| Vance D Coffman | Consejero | 30 de marzo de 2007 A | · | 0 | 0 | $0 |
| Robert E Allen | Consejero | 30 de marzo de 2007 A | 30 903 | 0 | 0 | $0 |
| Laurie H Glimcher MD | Consejero | 2 de mayo de 2006 A | · | 0 | 0 | $0 |
| Louis W Sullivan | Consejero | 31 de marzo de 2006 A | 8 400 | 0 | 0 | $0 |
| Louis V Gerstner JR | Consejero | 9 de marzo de 2006 M | 34 979 | 0 | 0 | $0 |
| Ellen V Futter | Consejero | 18 de agosto de 2005 S | 4 894 | 0 | 0 | $0 |
| Paula A Price | · | 1 de febrero de 2026 A | · | 0 | 0 | $0 |
| Nadim Ahmed | · | 31 de diciembre de 2020 M | 38 889 | 0 | 0 | $0 |
| Andrew R J Bonfield | · | 2 de marzo de 2008 F | 142 428 | 0 | 0 | $0 |
| BRISTOL MYERS SQUIBB CO | · | 18 de febrero de 2004 C | 2 079 002 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 205 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| RDIV · Invesco Exchange-Traded Fund Trust … | 5,33% | 1 237 467 SH | 23 de octubre de 2026 | Diario |
| IHE · iShares Trust | 4,84% | 1 229 395 SH | 11 de septiembre de 2026 | Diario |
| CAMX · ADVISORS' INNER CIRCLE FUND | 4,47% | 46 557 NS | 31 de julio de 2026 | N-PORT |
| SDG · iShares Trust | 3,92% | 102 563 SH | 11 de septiembre de 2026 | Diario |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 3,57% | 4 962 NS | 31 de julio de 2026 | N-PORT |
| DDDD · Tidal Trust II | 3,37% | 3 393 NS | 31 de julio de 2026 | N-PORT |
| PJP · Invesco Exchange-Traded Fund Trust | 2,91% | 258 583 SH | 23 de octubre de 2026 | Diario |
| ABFL · Abacus FCF ETF Trust | 2,88% | 232 064 NS | 31 de julio de 2026 | N-PORT |
| HDV · iShares Trust | 2,61% | 6 271 404 SH | 11 de septiembre de 2026 | Diario |
| ABOT · Abacus FCF ETF Trust | 2,61% | 1 613 NS | 31 de julio de 2026 | N-PORT |
| GEND · Spinnaker ETF Series | 2,29% | 1 704 NS | 31 de julio de 2026 | N-PORT |
| GCOW · Pacer Funds Trust | 2,19% | 1 154 625 NS | 31 de julio de 2026 | N-PORT |
| COWZ · Pacer Funds Trust | 2,18% | 6 242 303 NS | 31 de julio de 2026 | N-PORT |
| SPDV · ETF Series Solutions | 2,14% | 43 182 NS | 31 de julio de 2026 | N-PORT |
| IYH · iShares Trust | 2,10% | 1 195 391 SH | 11 de septiembre de 2026 | Diario |
| SPHD · Invesco Exchange-Traded Fund Trust … | 2,09% | 1 119 950 SH | 23 de octubre de 2026 | Diario |
| FHLC · FIDELITY COVINGTON TRUST | 1,93% | 971 248 NS | 31 de julio de 2026 | N-PORT |
| VLLU · Harbor ETF Trust | 1,81% | 1 284 NS | 31 de julio de 2026 | N-PORT |
| REVS · Columbia ETF Trust I | 1,79% | 91 255 NS | 31 de julio de 2026 | N-PORT |
| BMVP · Invesco Exchange-Traded Fund Trust | 1,75% | 28 971 SH | 23 de octubre de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 1,73% | 6 137 665 SH | 19 de agosto de 2026 | Diario |
| VMAX · Lattice Strategies Trust | 1,69% | 12 739 NS | 31 de julio de 2026 | N-PORT |
| IXJ · iShares Trust | 1,65% | 1 073 117 SH | 11 de septiembre de 2026 | Diario |
| PEY · Invesco Exchange-Traded Fund Trust | 1,60% | 285 457 SH | 23 de octubre de 2026 | Diario |
| NUDV · Nushares ETF Trust | 1,59% | 12 248 NS | 31 de julio de 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 1,54% | 247 112 NS | 31 de julio de 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 1,53% | 40 183 NS | 31 de julio de 2026 | N-PORT |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1,50% | 15 926 NS | 31 de julio de 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,50% | 228 437 SH | 23 de octubre de 2026 | Diario |
| FCPI · FIDELITY COVINGTON TRUST | 1,49% | 61 748 NS | 31 de julio de 2026 | N-PORT |
| JDIV · J.P. Morgan Exchange-Traded Fund Tr… | 1,41% | 2 772 NS | 31 de julio de 2026 | N-PORT |
| PWV · Invesco Exchange-Traded Fund Trust | 1,36% | 401 394 SH | 23 de octubre de 2026 | Diario |
| PILL · Direxion Shares ETF Trust | 1,34% | 4 226 NS | 31 de julio de 2026 | N-PORT |
| VUS · Virtus ETF Trust II | 1,25% | 3 408 NS | 31 de julio de 2026 | N-PORT |
| SRHQ · Elevation Series Trust | 1,19% | 38 523 NS | 31 de julio de 2026 | N-PORT |
| VLUE · iShares Trust | 1,16% | 1 748 175 SH | 11 de septiembre de 2026 | Diario |
| RECS · Columbia ETF Trust I | 1,16% | 1 035 838 NS | 31 de julio de 2026 | N-PORT |
| COWG · Pacer Funds Trust | 1,15% | 388 939 NS | 31 de julio de 2026 | N-PORT |
| LSVD · ADVISORS' INNER CIRCLE FUND | 1,10% | 109 100 NS | 31 de julio de 2026 | N-PORT |
| WLDR · Two Roads Shared Trust | 1,06% | 14 765 NS | 31 de julio de 2026 | N-PORT |
| JGLO · J.P. Morgan Exchange-Traded Fund Tr… | 1,05% | 1 073 325 NS | 31 de julio de 2026 | N-PORT |
| JOYT · J.P. Morgan Exchange-Traded Fund Tr… | 1,00% | 14 913 NS | 31 de julio de 2026 | N-PORT |
| EQWL · Invesco Exchange-Traded Fund Trust | 0,98% | 438 943 SH | 23 de octubre de 2026 | Diario |
| LCOW · Pacer Funds Trust | 0,96% | 3 783 NS | 31 de julio de 2026 | N-PORT |
| DUHP · Dimensional ETF Trust | 0,95% | 1 786 438 NS | 31 de julio de 2026 | N-PORT |
| QLC · FlexShares Trust | 0,94% | 145 152 NS | 31 de julio de 2026 | N-PORT |
| QDEF · FlexShares Trust | 0,93% | 77 490 NS | 31 de julio de 2026 | N-PORT |
| FDRR · FIDELITY COVINGTON TRUST | 0,93% | 104 452 NS | 31 de julio de 2026 | N-PORT |
| FLRG · FIDELITY COVINGTON TRUST | 0,92% | 40 873 NS | 31 de julio de 2026 | N-PORT |
| QDF · FlexShares Trust | 0,91% | 310 686 NS | 31 de julio de 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0,90% | 110 459 SH | 19 de agosto de 2026 | Diario |
| BKDV · BNY Mellon ETF Trust II | 0,89% | 250 811 NS | 31 de julio de 2026 | N-PORT |
| FTLS · First Trust Exchange-Traded Fund III | 0,87% | 331 913 NS | 31 de julio de 2026 | N-PORT |
| SNPV · DBX ETF Trust | 0,87% | 35 644 NS | 31 de agosto de 2026 | N-PORT |
| LSEQ · Harbor ETF Trust | 0,86% | 2 007 NS | 31 de julio de 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,84% | 122 977 SH | 19 de agosto de 2026 | Diario |
| DFVX · Dimensional ETF Trust | 0,79% | 63 410 NS | 31 de julio de 2026 | N-PORT |
| XT · iShares Trust | 0,74% | 452 984 SH | 11 de septiembre de 2026 | Diario |
| FHEQ · Fidelity Greenwood Street Trust | 0,74% | 105 853 NS | 31 de julio de 2026 | N-PORT |
| FBUF · Fidelity Greenwood Street Trust | 0,74% | 2 722 NS | 31 de julio de 2026 | N-PORT |
| FYEE · Fidelity Greenwood Street Trust | 0,74% | 24 743 NS | 31 de julio de 2026 | N-PORT |
| CLSE · Trust for Professional Managers | 0,73% | 98 626 NS | 31 de agosto de 2026 | N-PORT |
| SPMO · Invesco Exchange-Traded Fund Trust … | 0,73% | 2 458 394 SH | 23 de octubre de 2026 | Diario |
| DIVB · iShares Trust | 0,72% | 230 516 SH | 11 de septiembre de 2026 | Diario |
| DFUV · Dimensional ETF Trust | 0,72% | 1 694 116 NS | 31 de julio de 2026 | N-PORT |
| FQAL · FIDELITY COVINGTON TRUST | 0,68% | 147 701 NS | 31 de julio de 2026 | N-PORT |
| FVAL · FIDELITY COVINGTON TRUST | 0,68% | 138 783 NS | 31 de julio de 2026 | N-PORT |
| SPVM · Invesco Exchange-Traded Fund Trust | 0,67% | 14 820 SH | 23 de octubre de 2026 | Diario |
| CVAR · ETF Opportunities Trust | 0,65% | 4 281 NS | 31 de julio de 2026 | N-PORT |
| SPXD · DBX ETF Trust | 0,65% | 689 NS | 31 de agosto de 2026 | N-PORT |
| ROUS · Lattice Strategies Trust | 0,63% | 68 556 NS | 31 de julio de 2026 | N-PORT |
| DFLV · Dimensional ETF Trust | 0,61% | 631 900 NS | 31 de julio de 2026 | N-PORT |
| HELO · J.P. Morgan Exchange-Traded Fund Tr… | 0,60% | 422 920 NS | 31 de julio de 2026 | N-PORT |
| LGDX · Tidal Trust III | 0,58% | 12 564 NS | 31 de julio de 2026 | N-PORT |
| FTA · First Trust Exchange-Traded AlphaDE… | 0,57% | 121 890 NS | 31 de julio de 2026 | N-PORT |
| MGV · VANGUARD WORLD FUND | 0,56% | 1 283 512 SH | 19 de agosto de 2026 | Diario |
| RCGE · EA Series Trust | 0,56% | 8 536 NS | 31 de julio de 2026 | N-PORT |
| LRGF · iShares Trust | 0,55% | 316 783 SH | 11 de septiembre de 2026 | Diario |
| AFLG · First Trust Exchange-Traded Fund VI… | 0,53% | 60 228 NS | 31 de agosto de 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0,53% | 841 127 SH | 23 de octubre de 2026 | Diario |
| USXF · iShares Trust | 0,52% | 121 316 SH | 11 de septiembre de 2026 | Diario |
| VYM · VANGUARD WHITEHALL FUNDS | 0,49% | 8 151 149 SH | 19 de agosto de 2026 | Diario |
| JQUA · J.P. Morgan Exchange-Traded Fund Tr… | 0,49% | 612 521 NS | 31 de julio de 2026 | N-PORT |
| IWX · iShares Trust | 0,48% | 295 050 SH | 11 de septiembre de 2026 | Diario |
| PFM · Invesco Exchange-Traded Fund Trust | 0,46% | 58 000 SH | 23 de octubre de 2026 | Diario |
| LQAI · Exchange Listed Funds Trust | 0,44% | 150 NS | 31 de julio de 2026 | N-PORT |
| VTV · VANGUARD INDEX FUNDS | 0,44% | 19 418 659 SH | 19 de agosto de 2026 | Diario |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0,44% | 56 092 NS | 31 de julio de 2026 | N-PORT |
| DEUS · DBX ETF Trust | 0,44% | 19 762 NS | 31 de agosto de 2026 | N-PORT |
| IVE · iShares Trust | 0,44% | 3 392 410 SH | 11 de septiembre de 2026 | Diario |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0,43% | 564 000 | 23 de octubre de 2026 | Diario |
| IUSV · iShares Trust | 0,41% | 1 786 818 SH | 11 de septiembre de 2026 | Diario |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,41% | 470 234 SH | 19 de agosto de 2026 | Diario |
| USSG · DBX ETF Trust | 0,39% | 34 641 NS | 31 de agosto de 2026 | N-PORT |
| QARP · DBX ETF Trust | 0,39% | 4 541 NS | 31 de agosto de 2026 | N-PORT |
| IQSU · New York Life Investments ETF Trust | 0,39% | 19 446 NS | 31 de julio de 2026 | N-PORT |
| HQGO · Lattice Strategies Trust | 0,39% | 2 906 NS | 31 de julio de 2026 | N-PORT |
| SUSL · iShares Trust | 0,38% | 72 071 SH | 11 de septiembre de 2026 | Diario |
| ILCV · iShares Trust | 0,38% | 79 238 SH | 11 de septiembre de 2026 | Diario |
| DXUV · Dimensional ETF Trust | 0,37% | 31 098 NS | 31 de julio de 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,37% | 58 843 SH | 23 de octubre de 2026 | Diario |
| DSI · iShares Trust | 0,37% | 312 110 SH | 11 de septiembre de 2026 | Diario |
| EVUS · iShares Trust | 0,36% | 21 628 SH | 11 de septiembre de 2026 | Diario |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,36% | 25 146 NS | 31 de julio de 2026 | N-PORT |
| IWD · iShares Trust | 0,35% | 4 538 035 SH | 11 de septiembre de 2026 | Diario |
| BSCR · Invesco Exchange-Traded Self-Indexe… | 0,34% | 15 761 000 | 23 de octubre de 2026 | Diario |
| INFO · Harbor ETF Trust | 0,34% | 43 716 NS | 31 de julio de 2026 | N-PORT |
| AQLT · iShares Trust | 0,33% | 17 127 SH | 11 de septiembre de 2026 | Diario |
| ACVF · ETF Opportunities Trust | 0,33% | 7 798 NS | 31 de julio de 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,33% | 116 164 NS | 31 de julio de 2026 | N-PORT |
| SNPE · DBX ETF Trust | 0,33% | 146 785 NS | 31 de agosto de 2026 | N-PORT |
| GLOF · iShares Trust | 0,33% | 10 453 SH | 11 de septiembre de 2026 | Diario |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,33% | 1 232 885 SH | 19 de agosto de 2026 | Diario |
| IOO · iShares Trust | 0,32% | 446 878 SH | 11 de septiembre de 2026 | Diario |
| EGLE · Global X Funds | 0,31% | 104 NS | 31 de julio de 2026 | N-PORT |
| FEX · First Trust Exchange-Traded AlphaDE… | 0,31% | 73 364 NS | 31 de julio de 2026 | N-PORT |
| HEQQ · J.P. Morgan Exchange-Traded Fund Tr… | 0,30% | 1 395 NS | 31 de julio de 2026 | N-PORT |
| FDVV · FIDELITY COVINGTON TRUST | 0,30% | 471 606 NS | 31 de julio de 2026 | N-PORT |
| BSCU · Invesco Exchange-Traded Self-Indexe… | 0,29% | 9 468 000 | 23 de octubre de 2026 | Diario |
| ESG · FlexShares Trust | 0,29% | 5 790 NS | 31 de julio de 2026 | N-PORT |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,29% | 7 362 NS | 31 de julio de 2026 | N-PORT |
| OEF · iShares Trust | 0,27% | 864 634 SH | 11 de septiembre de 2026 | Diario |
| DCOR · Dimensional ETF Trust | 0,27% | 137 850 NS | 31 de julio de 2026 | N-PORT |
| USCL · iShares Trust | 0,24% | 108 081 SH | 11 de septiembre de 2026 | Diario |
| TOPC · iShares Trust | 0,24% | 1 236 SH | 11 de septiembre de 2026 | Diario |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,24% | 387 703 SH | 23 de octubre de 2026 | Diario |
| IWL · iShares Trust | 0,23% | 79 470 SH | 11 de septiembre de 2026 | Diario |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,23% | 62 000 SH | 23 de octubre de 2026 | Diario |
| JFLI · J.P. Morgan Exchange-Traded Fund Tr… | 0,23% | 1 678 NS | 31 de julio de 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,23% | 430 911 NS | 31 de julio de 2026 | N-PORT |
| XVV · iShares Trust | 0,22% | 23 537 SH | 11 de septiembre de 2026 | Diario |
| MGC · VANGUARD WORLD FUND | 0,22% | 407 968 SH | 19 de agosto de 2026 | Diario |
| APUE · Trust for Professional Managers | 0,22% | 80 213 NS | 31 de agosto de 2026 | N-PORT |
| ADME · ETF Series Solutions | 0,21% | 9 531 NS | 31 de julio de 2026 | N-PORT |
| TOV · EA Series Trust | 0,21% | 8 398 NS | 31 de julio de 2026 | N-PORT |
| XYLD · Global X Funds | 0,21% | 103 821 NS | 31 de julio de 2026 | N-PORT |
| ACIO · ETF Series Solutions | 0,21% | 75 134 NS | 31 de julio de 2026 | N-PORT |
| XRMI · Global X Funds | 0,21% | 1 584 NS | 31 de julio de 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0,21% | 103 030 NS | 31 de julio de 2026 | N-PORT |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,21% | 280 669 NS | 31 de julio de 2026 | N-PORT |
| BKLC · BNY Mellon ETF Trust | 0,21% | 172 308 NS | 31 de julio de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,21% | 1 507 287 NS | 31 de julio de 2026 | N-PORT |
| XTR · Global X Funds | 0,21% | 151 NS | 31 de julio de 2026 | N-PORT |
| XCLR · Global X Funds | 0,21% | 112 NS | 31 de julio de 2026 | N-PORT |
| VOTE · TCW ETF Trust | 0,20% | 34 427 NS | 31 de julio de 2026 | N-PORT |
| XYLG · Global X Funds | 0,20% | 2 006 NS | 31 de julio de 2026 | N-PORT |
| FEUS · FlexShares Trust | 0,20% | 3 465 NS | 31 de julio de 2026 | N-PORT |
| ESGV · VANGUARD WORLD FUND | 0,20% | 461 728 SH | 19 de agosto de 2026 | Diario |
| IVV · iShares Trust | 0,20% | 25 739 117 SH | 11 de septiembre de 2026 | Diario |
| PBP · Invesco Exchange-Traded Fund Trust | 0,20% | 12 248 SH | 23 de octubre de 2026 | Diario |
| SIZE · iShares Trust | 0,20% | 13 212 SH | 11 de septiembre de 2026 | Diario |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0,20% | 326 858 SH | 23 de octubre de 2026 | Diario |
| VOXP · Advisors Series Trust | 0,20% | 174 NS | 31 de julio de 2026 | N-PORT |
| ILCB · iShares Trust | 0,20% | 39 559 SH | 11 de septiembre de 2026 | Diario |
| DFUS · Dimensional ETF Trust | 0,19% | 622 639 NS | 31 de julio de 2026 | N-PORT |
| CRBN · iShares Trust | 0,19% | 35 573 SH | 11 de septiembre de 2026 | Diario |
| RSP · Invesco Exchange-Traded Fund Trust | 0,19% | 3 048 234 SH | 23 de octubre de 2026 | Diario |
| EUSA · iShares, Inc. | 0,19% | 57 715 SH | 11 de septiembre de 2026 | Diario |
| SPUU · Direxion Shares ETF Trust | 0,19% | 7 704 NS | 31 de julio de 2026 | N-PORT |
| VV · VANGUARD INDEX FUNDS | 0,19% | 2 384 889 SH | 19 de agosto de 2026 | Diario |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,19% | 142 089 SH | 23 de octubre de 2026 | Diario |
| QDPL · Pacer Funds Trust | 0,19% | 49 206 NS | 31 de julio de 2026 | N-PORT |
| IWB · iShares Trust | 0,19% | 1 413 452 SH | 11 de septiembre de 2026 | Diario |
| IYY · iShares Trust | 0,19% | 87 579 SH | 11 de septiembre de 2026 | Diario |
| VOO · VANGUARD INDEX FUNDS | 0,18% | 53 047 466 SH | 19 de agosto de 2026 | Diario |
| IWV · iShares Trust | 0,18% | 564 212 SH | 11 de septiembre de 2026 | Diario |
| ITOT · iShares Trust | 0,18% | 2 658 598 SH | 11 de septiembre de 2026 | Diario |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,17% | 337 846 SH | 19 de agosto de 2026 | Diario |
| PHDG · Invesco Actively Managed Exchange-T… | 0,17% | 1 609 SH | 23 de octubre de 2026 | Diario |
| HCMT · Direxion Shares ETF Trust | 0,16% | 14 207 NS | 31 de julio de 2026 | N-PORT |
| TILT · FlexShares Trust | 0,16% | 54 984 NS | 31 de julio de 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,16% | 64 840 247 SH | 19 de agosto de 2026 | Diario |
| VFMO · VANGUARD WELLINGTON FUND | 0,16% | 54 644 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,16% | 172 003 SH | 19 de agosto de 2026 | Diario |
| HDUS · Lattice Strategies Trust | 0,16% | 4 964 NS | 31 de julio de 2026 | N-PORT |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0,16% | 4 886 000 | 22 de octubre de 2026 | Diario |
| KOKU · DBX ETF Trust | 0,16% | 19 218 NS | 31 de agosto de 2026 | N-PORT |
| PEVC · Pacer Funds Trust | 0,16% | 58 NS | 31 de julio de 2026 | N-PORT |
| SPXL · Direxion Shares ETF Trust | 0,16% | 159 649 NS | 31 de julio de 2026 | N-PORT |
| TOK · iShares Trust | 0,15% | 5 742 SH | 11 de septiembre de 2026 | Diario |
| URTH · iShares, Inc. | 0,14% | 183 988 SH | 11 de septiembre de 2026 | Diario |
| ACWI · iShares Trust | 0,13% | 652 452 SH | 11 de septiembre de 2026 | Diario |
| ESGU · iShares Trust | 0,12% | 341 635 SH | 11 de septiembre de 2026 | Diario |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 0,11% | 4 046 000 | 20 de octubre de 2026 | Diario |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,10% | 1 700 877 SH | 19 de agosto de 2026 | Diario |
| SUSA · iShares Trust | 0,10% | 60 718 SH | 11 de septiembre de 2026 | Diario |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,09% | 11 815 SH | 23 de octubre de 2026 | Diario |
| ISCF · iShares Trust | 0,08% | 68 144 SH | 11 de septiembre de 2026 | Diario |
| ACWV · iShares, Inc. | 0,05% | 26 842 SH | 11 de septiembre de 2026 | Diario |
| DYNF · BlackRock ETF Trust | 0,05% | 330 996 SH | 11 de septiembre de 2026 | Diario |
| NPFE · Elevation Series Trust | 0,01% | 1 345 NS | 31 de julio de 2026 | N-PORT |
| GTO · Invesco Actively Managed Exchange-T… | 0,00% | 3 000 | 20 de octubre de 2026 | Diario |
| BIV · VANGUARD BOND INDEX FUNDS | · | · | 15 de julio de 2026 | Diario |
| BLV · VANGUARD BOND INDEX FUNDS | · | · | 15 de julio de 2026 | Diario |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | 15 de julio de 2026 | Diario |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 15 de julio de 2026 | Diario |
| VCRB · VANGUARD MALVERN FUNDS | · | · | 15 de julio de 2026 | Diario |
| VPLS · VANGUARD MALVERN FUNDS | · | · | 15 de julio de 2026 | Diario |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | 15 de julio de 2026 | Diario |
| VCIT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 de julio de 2026 | Diario |
| VCLT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 de julio de 2026 | Diario |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | 30 de julio de 2026 | Diario |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 30 de julio de 2026 | Diario |
| BNDX · VANGUARD CHARLOTTE FUNDS | · | · | 15 de julio de 2026 | Diario |
| VCEB · VANGUARD WORLD FUND | · | · | 30 de julio de 2026 | Diario |
BMY Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 34 analistas
COMPRA
Objetivo mediano
$65.50
+6,5%
7 20,6%
Compra fuerte
8 23,5%
Compra
18 52,9%
Mantener
1 2,9%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
24 analistas · 2026-10-19Objetivo medio $65.42 +6,4%
Ahora
Precio Actual $61.48
Mín$41.00
Media$65.42
Máx$82.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| BMY | · | 15.6 | -0.22% | 14.6% | 40.5% | · |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
| JNJ | · | 18.8 | 6.0% | 28.5% | 35.0% | 67.9% |
| MRK | · | 14.5 | 1.3% | 28.1% | 36.9% | · |
| PFE | · | 18.3 | -1.7% | 12.4% | 8.9% | · |
| RPRX | · | 21.7 | 5.1% | 32.4% | 8.0% | · |
| ZTS | $53.46B | 20.9 | 2.3% | 28.2% | 66.0% | · |
| VTRS | · | -4.2 | -3.0% | -24.6% | -23.2% | 35.1% |
| CORT | $3.69B | 42.4 | 12.8% | 13.1% | 15.5% | · |
| ELAN | $11.25B | -48.1 | 6.2% | -4.9% | -3.5% | 55.0% |
Últimas noticias Noticias recientes que mencionan a esta empresa
El plan 'Tu Primera Vivienda' de Burnham 'podría impulsar la producción de viviendas de Bellway en un 10%'
The Guardian ·
Is the Reported $400 Billion AstraZeneca-Bristol Myers Squibb Megamerger a Slam Dunk -- or a Disaster Waiting to Happen?
Nasdaq ·
Bristol Myers Squibb to build $2.3 billion Houston campus
Yahoo Finance ·
Exclusive-'No discussions' over AstraZeneca-Bristol Myers deal, senior source says
Yahoo Finance ·
The $400 Billion Reason Bristol-Myers Squibb (BMY) Stock Is Up Today
Yahoo Finance ·
Bristol Myers Squibb Stock Jumps on Reported Merger Talks With AstraZeneca
Yahoo Finance ·
$400 Billion Pharma Megadeal? Jefferies Calls Potential AstraZeneca-Bristol Myers Merger A "Head Scratcher"
ZeroHedge ·
AstraZeneca shares drop 7% after report on $400 billion merger talks with Bristol Myers Squibb
CNBC ·
Bill Ackman Runs a $14 Billion Fund on Just 11 Stocks. These Are His 3 Biggest Bets Right Now.
Nasdaq ·
Is Bristol-Myers Squibb Stock Underperforming the Dow?
Yahoo Finance ·
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Jul 30, 2026